MDS/MYELOPROLIFERATIVE NEOPLASM (MPN) OVERLAP SYNDROME

Clinical trials for MDS/MYELOPROLIFERATIVE NEOPLASM (MPN) OVERLAP SYNDROME explained in plain language.

Never miss a new study

Get alerted when new MDS/MYELOPROLIFERATIVE NEOPLASM (MPN) OVERLAP SYNDROME trials appear

Sign up with your email to follow new studies for MDS/MYELOPROLIFERATIVE NEOPLASM (MPN) OVERLAP SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo tested for Tough-to-Treat blood cancers

Disease control Completed

This early-stage study tested a new drug called PRT2527, both by itself and combined with other cancer drugs, in people with advanced blood cancers that had returned or stopped responding to standard treatments. The main goals were to find a safe dose and see if the treatments sh…

Matched conditions: MDS/MYELOPROLIFERATIVE NEOPLASM (MPN) OVERLAP SYNDROME

Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

MDS/MYELOPROLIFERATIVE NEOPLASM (MPN) OVERLAP SYNDROME

Get alerted when new MDS/MYELOPROLIFERATIVE NEOPLASM (MPN) OVERLAP SYNDROME trials appear

New drug combo tested for Tough-to-Treat blood cancers